Key facts
- This page summarizes K. Angela Macfarlane's Form 4 filing for RenovoRx, Inc. (RNXT).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 02 Oct 2025, 20:23.
K. Angela Macfarlane - 01 Oct 2025 Form 4 Insider Report for RenovoRx, Inc. (RNXT)
- Reporting relationship
- Director
- Issuer ticker
- RNXT
- Reported as of
- 01 Oct 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Oct 2025, 20:23:17 UTC
- Prior SEC filing
- 02 Oct 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ K. Angela Macfarlane
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
K. Angela Macfarlane filed Form 4 for RenovoRx, Inc. (RNXT) on 02 Oct 2025.
Change
- Previous filing in this sequence was filed on 02 Oct 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001865182
Primary reporting owner
Macfarlane K. Angela
- Relationship
- Director
- Address
- C/O RENOVORX, INC., 2570 W EL CAMINO REAL, SUITE 320, MOUNTAIN VIEW
- Signature
- /s/ K. Angela Macfarlane
- Signature date
- 02 Oct 2025
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RNXT
transaction
Derivative
Stock Options (right to buy)
Award
- Transaction value
- $0
- Shares
- +47,640
- Change %
- Price
- $0.000000
- Shares after
- 47,640
- Date
- 01 Oct 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 47,640
- Exercise price
- $1.34
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2025.